İrem UZUN -TDO- The European Commission will sign a deal to secure up to 300 million doses of the experimental coronavirus vaccine developed by BioNTech and Pfizer. Ursula von der Leyen, the president of the EU’s executive arm, said the commission will authorize the deal on Wednesday after “working tirelessly to secure doses of potential vaccines” in recent months. “This is the most promising vaccine so far,” von der Leyen said. “Once this vaccine becomes available, our plan is to deploy it quickly, everywhere in Europe.”
German Health Minister Jens Spahn said the vaccine is likely to be ready in the first quarter of 2021 and hopes to secure 100 million doses for Germany. Spahn said it's important that Germany and the rest of the EU don't fall behind in the vaccine rollout. "We of course couldn't explain to Europeans and especially to Germans if a vaccine would be available and distributed in the U.S. or in other regions in the world, but not in Germany and Europe." Spahn emphasized that the European Commission had the mandate to negotiate with pharmaceutical companies - not individual states. France, Germany, Spain and others in the bloc "absolutely" would have been able to secure national contracts, Spahn said.